Business Description
Affimed N.V. is a biopharmaceutical company based in Mannheim, Germany, focused on developing cancer treatments that work by activating the body's own immune cells. The company is advancing several drug candidates through clinical and preclinical stages, targeting blood cancers and solid tumors. Affimed works alongside partners such as Artiva Biotherapeutics, Roivant Sciences, and Genentech to broaden the reach of its pipeline and bring new treatment options to patients.
